Dr. Ronald Levy is a Professor of Medicine and Chief of the Division of Oncology in the Department of Medicine at Stanford University. Dr. Levy is also an American Cancer Society Clinical Research Professor. Dr. Levy, a Harvard graduate, received his medical degree from Stanford. In 1982 he shared the first Armand Hammer Award for Cancer Research; the next year he received the Ciba-Geigy/Drew Award in Biomedical Research. In 1999 he received the American Society of Clinical Oncology Karnofsky Award and the prestigious General Motors Charles Kettering Prize. In 2000 he was awarded the Key to the Cure Award by the Cure for Lymphoma Foundation and the Medal of Honor by the American Cancer Society. In 2001 he was awarded the Evelyn Hoffman Memorial Award by the Lymphoma Research Foundation of America. In 2003 Dr. Levy was awarded the Jeffrey A. Gottlieb Memorial Award, from the Anderson Cancer Center. Most recently Dr. Levy has been awarded the Damashek Prize from the American Society of Hematology.
Dr. Levy has received international acclaim for his work using the body's own arsenal to fight cancer. He is currently conducting clinical trials of a lymphoma vaccine. His research concentrates on the study of malignant lymphoma, which are tumors of the immune system, using the tools of immunology and molecular biology to develop a better understanding of the initiation and progression of the malignant process. Receptor molecules present on the surface of tumor cells transmit signals for regulation of cell growth; these receptors include the immunoglobulin molecule on B cell tumors, the T cell receptor on T cell tumors. Dr. Levy is using these receptors as targets for new therapies for lymphoma. Dr. Levy has published over 250 articles in the fields of oncology and immunology.
(Biography as of November 2006)
